Moderna Inc (MRNA)

$62.96 -1.50 (-2.33%)
Market Cap 25.73B
Revenue (ttm) 1.94B
Net Income (ttm) -2.82B
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -145.16%
Debt to Equity Ratio 0.09
Volume 4,299,700
Avg Vol 7,253,418
Day's Range N/A - N/A
Shares Out 399.24M
Stochastic %K 78%
Beta 0.91
Analysts Hold
Price Target $53.19

Company Profile

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseas...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 714 6500
Address:
325 Binney Street, Cambridge, United States
AshHydrogen
AshHydrogen Aug. 19 at 12:48 PM
$PLTR Dr Karp get more RETAIL IN PLTR before we have our $MRNA moment!!! Have Chad Wallquist go on Cramer and talk FDE!!! MORE VIZ BIZ https://media.stocktwits-cdn.com/api/3/media/4280971/default.png
0 · Reply
SSom
SSom Aug. 19 at 12:48 PM
$PACB $MRNA What if personalized oncology becomes the next major application for sequencing? MRNA’s breakthrough today could validate a much larger precision-oncology market. $PACB is trading at a tiny fraction of the valuations of many biotech names. How undervalued could PacBio be if HiFi sequencing becomes part of the personalized cancer workflow?
0 · Reply
Uphighup
Uphighup Aug. 19 at 12:48 PM
$MRNA I wonder if I short here, would I get burned or I’ll make a couple of dollars?
0 · Reply
RuthLanzilotta111
RuthLanzilotta111 Aug. 19 at 12:48 PM
$MRNA
0 · Reply
jliebs12
jliebs12 Aug. 19 at 12:48 PM
$MRNA shorts are ethically fucked!
0 · Reply
IcecoldBro
IcecoldBro Aug. 19 at 12:47 PM
$MRNA this has the potential to be the start of one of the biggest developments in human history
0 · Reply
eightytwentie
eightytwentie Aug. 19 at 12:47 PM
$BNTX $MRNA @Samishere What say you? What say you now you dumb kunt ?
0 · Reply
mz08
mz08 Aug. 19 at 12:47 PM
$MRNA
0 · Reply
Donniechen12345
Donniechen12345 Aug. 19 at 12:47 PM
$MRNA once the gap fills , they willmsell as you buy smh even though immbullish i see that crap smh
0 · Reply
mz08
mz08 Aug. 19 at 12:47 PM
$MRNA
0 · Reply
Latest News on MRNA
Moderna extends rally, shares up 89% to $118.99 after melonoma data

2026-08-19T12:41:01.000Z - 7 minutes ago

Moderna extends rally, shares up 89% to $118.99 after melonoma data

Moderna Shares Skyrocket 85% Toward Best Day Ever—On Success Of Cancer Drug Trial

Aug 19, 2026, 8:40 AM EDT - 8 minutes ago

Moderna Shares Skyrocket 85% Toward Best Day Ever—On Success Of Cancer Drug Trial

Why is Moderna stock up 87% today during premarket trade?

Aug 19, 2026, 8:39 AM EDT - 9 minutes ago

Why is Moderna stock up 87% today during premarket trade?

Moderna upgraded to Outperform from Market Perform at William Blair

2026-08-19T12:36:13.000Z - 12 minutes ago

Moderna upgraded to Outperform from Market Perform at William Blair

William Blair upgrades Moderna to Outperform on ‘clear positive’ data

2026-08-19T12:35:23.000Z - 13 minutes ago

William Blair upgrades Moderna to Outperform on ‘clear positive’ data

'An increased ability to disease-free': Moderna CEO & Merck's Dr. Li on skin cancel vaccine trial

Aug 19, 2026, 8:29 AM EDT - 19 minutes ago

'An increased ability to disease-free': Moderna CEO & Merck's Dr. Li on skin cancel vaccine trial

MRK

Moderna's stock doubles on promising cancer-vaccine results

Aug 19, 2026, 8:15 AM EDT - 33 minutes ago

Moderna's stock doubles on promising cancer-vaccine results

Moderna Stock Soars 100% after “Landmark” Phase 3 Cancer Trial Win in Melanoma

2026-08-19T12:07:01.000Z - 41 minutes ago

Moderna Stock Soars 100% after “Landmark” Phase 3 Cancer Trial Win in Melanoma

MRK

Why Is Moderna Stock (MRNA) Surging Over 100% in Pre-Market Today, August 19?

2026-08-19T12:05:49.000Z - 42 minutes ago

Why Is Moderna Stock (MRNA) Surging Over 100% in Pre-Market Today, August 19?

MRK

Moderna, Merck, La-Z-Boy, SK Hynix, and More Stocks That Explain Today's Market

Aug 19, 2026, 7:35 AM EDT - 1 hour ago

Moderna, Merck, La-Z-Boy, SK Hynix, and More Stocks That Explain Today's Market

LZB MRK SKHY

Moderna jumps 54% to $97.52 after Phase 3 INTerpath-001 trial met endpoints

2026-08-19T11:00:14.000Z - 1 hour ago

Moderna jumps 54% to $97.52 after Phase 3 INTerpath-001 trial met endpoints

MRK

Merck, Moderna: Phase 3 INTerpath-001 trial met endpoints

2026-08-19T10:50:25.000Z - 1 hour ago

Merck, Moderna: Phase 3 INTerpath-001 trial met endpoints

MRK

Merck, Moderna say melanoma skin cancer vaccine meets goals in large trial

Aug 19, 2026, 6:48 AM EDT - 2 hours ago

Merck, Moderna say melanoma skin cancer vaccine meets goals in large trial

MRK

Personalized cancer vaccine from Moderna, Merck shows promise in first late-stage melanoma trial

Aug 19, 2026, 6:46 AM EDT - 2 hours ago

Personalized cancer vaccine from Moderna, Merck shows promise in first late-stage melanoma trial

MRK

An experimental mRNA-based cancer vaccine succeeded in preventing melanoma from coming back or spreading in a large study, partners Merck and Moderna said.

Aug 19, 2026, 6:45 AM EDT - 2 hours ago

An experimental mRNA-based cancer vaccine succeeded in preventing melanoma from coming back or spreading in a large study, partners Merck and Moderna said.

MRK

Merck and Moderna Announce Phase 3 INTerpath-001 Trial of Intismeran Autogene Plus KEYTRUDA® Met Endpoints of Recurrence-Free Survival (RFS) and Distant Metastasis-Free Survival (DMFS) in Patients With Completely Resected Stage IIB-IV Melanoma

Aug 19, 2026, 6:45 AM EDT - 2 hours ago

Merck and Moderna Announce Phase 3 INTerpath-001 Trial of Intismeran Autogene Plus KEYTRUDA® Met Endpoints of Recurrence-Free Survival (RFS) and Distant Metastasis-Free Survival (DMFS) in Patients With Completely Resected Stage IIB-IV Melanoma

MRK

These New Drugs Could Fuel Fresh Highs for Biotech and Pharma Stocks

Aug 7, 2026, 1:15 AM EDT - 12 days ago

These New Drugs Could Fuel Fresh Highs for Biotech and Pharma Stocks

IBB IHE MRK PJP SMMT XBI

This new kind of flu shot by Moderna has just been approved by the FDA

Aug 6, 2026, 4:21 PM EDT - 12 days ago

This new kind of flu shot by Moderna has just been approved by the FDA

Moderna Stock Flashing Intriguing ‘Buy The Dip' Signal

Aug 6, 2026, 2:35 PM EDT - 12 days ago

Moderna Stock Flashing Intriguing ‘Buy The Dip' Signal

Moderna Stock Slips Despite FDA Approval for New Flu Shot mFlusiva

2026-08-06T15:37:47.000Z - 12 days ago

Moderna Stock Slips Despite FDA Approval for New Flu Shot mFlusiva

Moderna Stock Rises as Flu Vaccine Approval Offers Spark for a Post-Pandemic Future

Aug 6, 2026, 8:26 AM EDT - 13 days ago

Moderna Stock Rises as Flu Vaccine Approval Offers Spark for a Post-Pandemic Future

Sandisk, AppLovin, Moderna, and More Stocks That Explain Today's Market

Aug 6, 2026, 6:42 AM EDT - 13 days ago

Sandisk, AppLovin, Moderna, and More Stocks That Explain Today's Market

APP SNDK

Moderna receives FDA approval for mFlusiva in adults 50 years, older

2026-08-06T09:35:40.000Z - 13 days ago

Moderna receives FDA approval for mFlusiva in adults 50 years, older

Moderna Stock (MRNA) Jumps on U.S. Approval for New Flu Shot Type — Why This Matters

2026-08-06T08:36:15.000Z - 13 days ago

Moderna Stock (MRNA) Jumps on U.S. Approval for New Flu Shot Type — Why This Matters

FDA Approves First mRNA Flu Vaccine For Older Adults

Aug 6, 2026, 3:10 AM EDT - 13 days ago

FDA Approves First mRNA Flu Vaccine For Older Adults

The Food and Drug Administration approved Moderna's mRNA flu vaccine, the first of its kind, capping a review that nearly collapsed in February.

Aug 5, 2026, 10:27 PM EDT - 13 days ago

The Food and Drug Administration approved Moderna's mRNA flu vaccine, the first of its kind, capping a review that nearly collapsed in February.

US FDA approves first mRNA flu shot from Moderna

Aug 5, 2026, 10:20 PM EDT - 13 days ago

US FDA approves first mRNA flu shot from Moderna

Moderna Receives U.S. FDA Approval for Influenza Vaccine mFLUSIVA

Aug 5, 2026, 10:15 PM EDT - 13 days ago

Moderna Receives U.S. FDA Approval for Influenza Vaccine mFLUSIVA

Moderna Stock Jumps on Trial Launch for Breakthrough Ebola Vaccine

Aug 4, 2026, 12:35 PM EDT - 14 days ago

Moderna Stock Jumps on Trial Launch for Breakthrough Ebola Vaccine

Moderna announces initiation of Phase 1 trial of mRNA-1469

2026-08-04T15:05:23.000Z - 14 days ago

Moderna announces initiation of Phase 1 trial of mRNA-1469

Moderna begins first human trial of Bundibugyo Ebola vaccine

Aug 4, 2026, 11:03 AM EDT - 14 days ago

Moderna begins first human trial of Bundibugyo Ebola vaccine

Moderna Announces Initiation of Phase 1 Clinical Trial of mRNA-1469, Moderna's Investigational Vaccine Against Bundibugyo Ebolavirus

Aug 4, 2026, 11:00 AM EDT - 14 days ago

Moderna Announces Initiation of Phase 1 Clinical Trial of mRNA-1469, Moderna's Investigational Vaccine Against Bundibugyo Ebolavirus

Moderna price target raised to $60 from $41 at Citi

2026-08-03T10:41:57.000Z - 16 days ago

Moderna price target raised to $60 from $41 at Citi

Moderna Wins a Post-COVID Earnings Beat as Analyst Eyes ‘Clinically Meaningful’ Trial Results

2026-07-31T15:04:57.000Z - 18 days ago

Moderna Wins a Post-COVID Earnings Beat as Analyst Eyes ‘Clinically Meaningful’ Trial Results

JEF MRK

Moderna Earnings Call Transcript: Q2 2026

Jul 31, 2026, 8:00 AM EDT - 19 days ago

Moderna Earnings Call Transcript: Q2 2026

Moderna Earnings release: Q2 2026

Jul 31, 2026, 8:00 AM EDT - 19 days ago

Moderna Earnings release: Q2 2026

Moderna Slides: Q2 2026

Jul 31, 2026, 8:00 AM EDT - 19 days ago

Moderna Slides: Q2 2026

Moderna Quarterly report: Q2 2026

Jul 31, 2026, 8:00 AM EDT - 19 days ago

Moderna Quarterly report: Q2 2026

Moderna Narrows Loss, Says New Norovirus Vaccine Didn't Meet Expectations

Jul 31, 2026, 7:45 AM EDT - 19 days ago

Moderna Narrows Loss, Says New Norovirus Vaccine Didn't Meet Expectations

Moderna Earnings Are Better Than Expected So Why Is the Stock Falling?

Jul 31, 2026, 7:26 AM EDT - 19 days ago

Moderna Earnings Are Better Than Expected So Why Is the Stock Falling?

Moderna sees FY26 cost of sales $1.7B, down from prior $1.8B view

2026-07-31T11:11:53.000Z - 19 days ago

Moderna sees FY26 cost of sales $1.7B, down from prior $1.8B view

Moderna misses quarterly revenue estimates on COVID vaccine weakness

Jul 31, 2026, 7:04 AM EDT - 19 days ago

Moderna misses quarterly revenue estimates on COVID vaccine weakness

Moderna Reports Second Quarter 2026 Financial Results and Provides Business Updates

Jul 31, 2026, 7:00 AM EDT - 19 days ago

Moderna Reports Second Quarter 2026 Financial Results and Provides Business Updates

Moderna Announces First Participant Dosed in Phase 1 Clinical Trial Evaluating Investigational Tumor-Targeted Cancer Antigen Therapy in Solid Tumors

Jul 16, 2026, 7:00 AM EDT - 4 weeks ago

Moderna Announces First Participant Dosed in Phase 1 Clinical Trial Evaluating Investigational Tumor-Targeted Cancer Antigen Therapy in Solid Tumors

Moderna wins EU contract for RSV vaccine supply

Jul 9, 2026, 7:17 AM EDT - 5 weeks ago

Moderna wins EU contract for RSV vaccine supply

Moderna to Report Second Quarter 2026 Financial Results on Friday, July 31, 2026

Jul 9, 2026, 7:00 AM EDT - 5 weeks ago

Moderna to Report Second Quarter 2026 Financial Results on Friday, July 31, 2026

Moderna Appoints Michael McDonnell to Board of Directors

Jul 8, 2026, 7:00 AM EDT - 6 weeks ago

Moderna Appoints Michael McDonnell to Board of Directors

Moderna stock jumps as pipeline progress and flu shot data lift sentiment

Jul 2, 2026, 3:51 PM EDT - 6 weeks ago

Moderna stock jumps as pipeline progress and flu shot data lift sentiment

Jim Cramer says this former Covid market darling is finally investable again

Jul 1, 2026, 6:50 PM EDT - 6 weeks ago

Jim Cramer says this former Covid market darling is finally investable again

The 20 best-performing stocks in the S&P 500 for the first half of 2026

Jun 30, 2026, 7:34 AM EDT - 7 weeks ago

The 20 best-performing stocks in the S&P 500 for the first half of 2026

AMD CIEN COHR DELL FIX FLEX GLW

AshHydrogen
AshHydrogen Aug. 19 at 12:48 PM
$PLTR Dr Karp get more RETAIL IN PLTR before we have our $MRNA moment!!! Have Chad Wallquist go on Cramer and talk FDE!!! MORE VIZ BIZ https://media.stocktwits-cdn.com/api/3/media/4280971/default.png
0 · Reply
SSom
SSom Aug. 19 at 12:48 PM
$PACB $MRNA What if personalized oncology becomes the next major application for sequencing? MRNA’s breakthrough today could validate a much larger precision-oncology market. $PACB is trading at a tiny fraction of the valuations of many biotech names. How undervalued could PacBio be if HiFi sequencing becomes part of the personalized cancer workflow?
0 · Reply
Uphighup
Uphighup Aug. 19 at 12:48 PM
$MRNA I wonder if I short here, would I get burned or I’ll make a couple of dollars?
0 · Reply
RuthLanzilotta111
RuthLanzilotta111 Aug. 19 at 12:48 PM
$MRNA
0 · Reply
jliebs12
jliebs12 Aug. 19 at 12:48 PM
$MRNA shorts are ethically fucked!
0 · Reply
IcecoldBro
IcecoldBro Aug. 19 at 12:47 PM
$MRNA this has the potential to be the start of one of the biggest developments in human history
0 · Reply
eightytwentie
eightytwentie Aug. 19 at 12:47 PM
$BNTX $MRNA @Samishere What say you? What say you now you dumb kunt ?
0 · Reply
mz08
mz08 Aug. 19 at 12:47 PM
$MRNA
0 · Reply
Donniechen12345
Donniechen12345 Aug. 19 at 12:47 PM
$MRNA once the gap fills , they willmsell as you buy smh even though immbullish i see that crap smh
0 · Reply
mz08
mz08 Aug. 19 at 12:47 PM
$MRNA
0 · Reply
VanHsu
VanHsu Aug. 19 at 12:47 PM
$MRNA Great chance to do scalp, 100 in 130 out, I dont know this company, but good luck to all the guys who hold it
1 · Reply
josephe87
josephe87 Aug. 19 at 12:47 PM
$MRNA is alive?
0 · Reply
Tradingistheway
Tradingistheway Aug. 19 at 12:47 PM
$MRNA $SXTC
0 · Reply
Diamondhands2121
Diamondhands2121 Aug. 19 at 12:47 PM
$MRNA LFG !
0 · Reply
grxthy
grxthy Aug. 19 at 12:47 PM
$MRNA holy moly. Congrats longs
0 · Reply
Hes0yam
Hes0yam Aug. 19 at 12:46 PM
$MRNA wow..sell on opening!
0 · Reply
Donniechen12345
Donniechen12345 Aug. 19 at 12:46 PM
$MRNA
0 · Reply
TopazFrenzy
TopazFrenzy Aug. 19 at 12:46 PM
$MRNA Funds are going to dump all their shares creating new bagholders today 😂
0 · Reply
dewmoore
dewmoore Aug. 19 at 12:46 PM
$SLS Here's why I'm sooo happy today! $MRNA just added $25B in market cap for a skin cancer vaccine targeting a $4-5B melanoma market—proving that breakthrough tech gets instantly massive valuations. If you thought I was crazy for calling a $100+ target before, look at the math. With a $4B addressable market scaling up for Acute Myeloid Leukemia (AML) and $SLS sitting down at $13, a massive re-rating is right in front of us when REGAL hits. Patience pays. Bullish AF! $SLS $MRNA$MRK
0 · Reply
Juststartingout14
Juststartingout14 Aug. 19 at 12:46 PM
$MRNA Covid high - $495 Cancer vaccine - ??
0 · Reply
Donniechen12345
Donniechen12345 Aug. 19 at 12:46 PM
$MRNA second moutain iat at $134 .. party over same like docs smh
0 · Reply
MisterSplashyPants
MisterSplashyPants Aug. 19 at 12:46 PM
$MRNA Good morning. A great day for science. And a bad day for people who peaked in high school and found their voice on the internet.
0 · Reply